Ehret, F., Abid, F. B., Ribeiro, V. T., Bodden, R., Maluf, F. C., Larco-Castilla, P., Naud, L. M., Ferraz de Paula Soares, C., Shaikh, E., Valente de Camargo, L., & Ridolfi, F. M. (2020). The IDEAL trial - a study protocol for a phase III randomized, double-blinded clinical trial assessing the ultra-short antibiotic prophylaxis of Isoniazid and Rifapentine in non-immunosuppressed patients with newly diagnosed latent tuberculosis. Principles and Practice of Clinical Research, 6(1), 9–14. Retrieved from https://journal2.teste.pro.br/index.php/ppcrjournal/article/view/96